Cargando…

Anticancer Effects of 15d-Prostaglandin-J(2) in Wild-Type and Doxorubicin-Resistant Ovarian Cancer Cells: Novel Actions on SIRT1 and HDAC

15-deoxy-delta-12,14-prostaglandin-J(2) (15d-PGJ(2)), an arachidonic metabolite and a natural PPARγ agonist, is known to induce apoptosis in tumor cells. In this study, we investigated new therapeutic potentials of 15d-PGJ(2) by determining its anticancer effects in wild-type and doxorubicin-resista...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jong, Edwin, Winkel, Peter, Poelstra, Klaas, Prakash, Jai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177888/ https://www.ncbi.nlm.nih.gov/pubmed/21957481 http://dx.doi.org/10.1371/journal.pone.0025192

Ejemplares similares

Targeting 15d-Prostaglandin J(2) to Hepatic Stellate Cells: Two Options Evaluated
por: Hagens, Werner I., et al.
Publicado: (2007)

Synergistic effects of 15-deoxy Δ(12,14)-prostaglandin J(2) on the anti-tumor activity of doxorubicin in renal cell carcinoma
por: Yamamoto, Yasuhiro, et al.
Publicado: (2016)

Targeted Recombinant Fusion Proteins of IFNγ and Mimetic IFNγ with PDGFβR Bicyclic Peptide Inhibits Liver Fibrogenesis In Vivo
por: Bansal, Ruchi, et al.
Publicado: (2014)

Novel SIRT1 inhibitor 15-deoxy-Δ(12,14)-prostaglandin J(2) and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells
por: Tae, In Hwan, et al.
Publicado: (2018)

15-deoxy-Δ(12, 14)-prostaglandin J(2) enhances anticancer activities independently of VHL status in renal cell carcinomas
por: Koma, Hiromi, et al.
Publicado: (2019)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
por: Goehringer, Nils, et al.
Publicado: (2021)

15-deoxy-Δ(12,14)-prostaglandin J(2) in neurodegenerative diseases and cancers
por: Yagami, Tatsurou, et al.
Publicado: (2017)

15-Deoxy-△(12,14)-Prostaglandin J(2) Promotes Resolution of Experimentally Induced Colitis
por: Kim, Wonki, et al.
Publicado: (2021)

15-deoxy-delta(12,14)-prostaglandin J(2 )induces apoptosis in human articular chondrocytes
por: Masuko-Hongo, K, et al.
Publicado: (2003)

Rac1 modification by an electrophilic 15-deoxy Δ(12,14)-prostaglandin J(2) analog
por: Wall, S.B., et al.
Publicado: (2015)

Synthesis and Evaluation of C15 Triene Urushiol Derivatives as Potential Anticancer Agents and HDAC2 Inhibitor
por: Qi, Zhiwen, et al.
Publicado: (2018)

Hydropersulfides (RSSH) attenuate doxorubicin-induced cardiotoxicity while boosting its anticancer action
por: Pharoah, Blaze M., et al.
Publicado: (2023)

Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
por: Cross, Jasmine M., et al.
Publicado: (2020)

15-Deoxy-∆-(12,14)-Prostaglandin J2 (15d-PGJ2), an Endogenous Ligand of PPAR-γ: Function and Mechanism
por: Li, Jingjing, et al.
Publicado: (2019)

Feedback Control of the Arachidonate Cascade in Osteoblastic Cells by 15-deoxy-Δ(12,14)-Prostaglandin J(2)
por: Ishino, Hidetaka, et al.
Publicado: (2008)

Changes in the Th1 : Th2 Cytokine Bias in Pregnancy and the Effects of the Anti-Inflammatory Cyclopentenone Prostaglandin 15-Deoxy-Δ(12,14)-Prostaglandin J(2)
por: Sykes, Lynne, et al.
Publicado: (2012)

Increased Liver Uptake and Reduced Hepatic Stellate Cell Activation with a Cell-Specific Conjugate of the Rho-kinase Inhibitor Y27632
por: van Beuge, Marike Marjolijn, et al.
Publicado: (2011)

Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury
por: van Beuge, Marike Marjolijn, et al.
Publicado: (2013)

The anticancer effects of HDAC inhibitors require the immune system
por: West, Alison C, et al.
Publicado: (2014)

15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases
por: Prasad, Ratna, et al.
Publicado: (2008)

Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Macrophage Colonization by Salmonella enterica Serovar Typhimurium
por: Buckner, Michelle M. C., et al.
Publicado: (2013)

Effects of 15-Deoxy-Δ(12,14)-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2(+) T Cells
por: Li, Haishan, et al.
Publicado: (2009)

Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
por: Salvati, Anna, et al.
Publicado: (2022)

Synthetic (N,N-Dimethyl)doxorubicin Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline Anticancer Drugs
por: Wander, Dennis P. A., et al.
Publicado: (2021)

Mitotic H3K9ac is controlled by phase-specific activity of HDAC2, HDAC3, and SIRT1
por: Gandhi, Shashi, et al.
Publicado: (2022)

Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1
por: Pfister, Jason A., et al.
Publicado: (2019)

15-Deoxy-Δ(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice
por: Seno, Takahiro, et al.
Publicado: (2011)

Correction: Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

15-Deoxy-Delta-12,14-Prostaglandin J(2) Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma
por: Coutinho, Diego S., et al.
Publicado: (2017)

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
por: Kciuk, Mateusz, et al.
Publicado: (2023)

Structural Insights into Novel 15-Prostaglandin Dehydrogenase Inhibitors
por: Mallipeddi, Prema L., et al.
Publicado: (2021)

Evaluation of the Stability, Bioavailability, and Hypersensitivity of the Omega-3 Derived Anti-Leukemic Prostaglandin: Δ(12)-Prostaglandin J(3)
por: Kudva, Avinash K., et al.
Publicado: (2013)

Hypothalamic Actions of SIRT1 and SIRT6 on Energy Balance
por: Quiñones, Mar, et al.
Publicado: (2021)

15-Deoxy-Δ(12,14)-prostaglandin J(2) Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells
por: Trindade-da-Silva, Carlos Antônio, et al.
Publicado: (2016)

15-Deoxy-Δ(12,14)-Prostaglandin J(2) Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells
por: Marcone, Simone, et al.
Publicado: (2016)

The Effects of Co-Treatment of 9-cis-Retinoic Acid and 15-Deoxy-Δ (12,14)-prostaglandin J2 on Microglial Activation
por: Hsu, Pei-Chien, et al.
Publicado: (2011)

Effect of 15-Deoxy-∆(12,14)-prostaglandin J(2) Nanocapsules on Inflammation and Bone Regeneration in a Rat Bone Defect Model
por: Tang, Qi, et al.
Publicado: (2017)

Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro
por: Kawakita, Takako, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q34sv09pcv826e0iojlqu7skmp